IMUX
Immunic Inc
9.40$
-13.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 97.4% | 96.7% | 98.5% | 98.3% | 97.7% | 96.2% | 92.5% | 97.4% | 96.5% | 95.1% | 99.5% | 99.2% | |
| 89.1% | 86.0% | 93.4% | 92.1% | 91.2% | 87.3% | 69.7% | 90.0% | 86.3% | 64.4% | 98.4% | 97.4% | |
| 89.1% | 86.0% | 93.4% | 92.1% | 91.2% | 87.3% | 69.7% | 90.0% | 86.3% | 64.4% | 98.4% | 97.4% | |
| 1.8% | 1.3% | 1.4% | 1.7% | 1.3% | 1.7% | 3.1% | 1.0% | 0.4% | 17.1% | 0.2% | – | |
| 3.4% | – | – | – | – | – | – | – | – | – | – | – | |
| 27.7% | 46.7% | 19.8% | 26.5% | 36.4% | 54.9% | 125.8% | 44.8% | 74.2% | 127.7% | 20.3% | 19.8% | |
| 26.5% | 45.5% | 19.3% | 26.2% | 36.1% | 54.3% | 124.7% | 44.5% | 73.9% | 127.3% | 20.2% | 19.6% | |
| 1.0% | 1.3% | 0.7% | 0.8% | 1.1% | 1.8% | 3.7% | 1.3% | 1.6% | 2.0% | 0.1% | 0.2% | |
| 4.8% | 9.4% | 6.0% | 8.8% | 8.9% | 19.2% | 26.8% | 12.8% | 18.1% | 42.2% | 5.5% | 8.0% | |
| 72.3% | 53.3% | 80.2% | 73.5% | 63.6% | 45.1% | -25.8% | 55.2% | 25.8% | -27.7% | 79.7% | 80.2% | |
| -581.3% | -756.7% | -422.9% | -534.0% | -750.8% | -1,251.3% | -2,617.0% | -917.6% | -1,447.7% | -2,530.2% | -337.9% | -424.2% | |
| 6.7% | 8.2% | 9.3% | 11.7% | 15.6% | 22.1% | 49.4% | 21.5% | 47.6% | 50.1% | 15.9% | 26.7% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.